Maria Łuniewska

Maria Łuniewska

Auto-generated profile, based on publicly available information

Maria Łuniewska

Mazovian Regional Hospital

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
INIga Nowicka
Iga Nowicka
BŁBartosz Łuniewski
Bartosz Łuniewski
AMAngelika Macko
Angelika Macko
MŁMaria Łuniewska
Maria Łuniewska
PTPaweł Rios Turek
Paweł Rios Turek
Background: Physical activity is important for prevention of some of the most common diseases worldwide: cardiovascular disease, type 2 diabetes mellitus, and certain types of cancers. However, extremely strenuous exercise performed over a prolonged period can lead to Overtraining Syndrome (OTS), especially in athletes competing at elite levels. This is characterized by psychological, neuroendocrine and immunological disturbance, and a prolonged decrease in exercise tolerability. Although many theories have emerged about the etiology of this condition, the pathophysiology is still unknown. That makes it difficult to diagnose OTS, as the resulting symptoms, including fatigue and diminished exercise performance, are common in athletes and largely nonspecific. Aim: The goal of this study was to synthesize current evidence on possible hormonal biomarkers that may assist in the diagnosis of OTS. Materials and methods: The search was conducted via PubMed, Science Direct, NCBI, and Google Scholar databases for articles with a focus on human studies. The keywords included “overtraining syndrome”, “OTS”, “overreaching syndrome”, “hormonal biomarkers”, “testosterone cortisol ratio”, “testosterone estradiol ratio”, “hypothalamic pituitary axis”, “hypothalamic dysfunction”, “EROS-HPA axis”. Results: Certain studies suggest that basal and dynamic hormone measurements may aid in the diagnosis of OTS. The Cadegiani and Kater EROS studies (2017-2020) [9, 10, 11] have proposed diagnostic tools composed of clinical and biological markers that, in the tested cohort, showed 100% diagnostic accuracy in distinguishing between OTS and non-OTS athletes. However, without an established pathophysiological pathway, many researchers remain sceptical. Conclusions: There is a definite need for validation of proposed diagnostic tools and reaching a consensus on the diagnostic process of OTS, instead of having it be a diagnosis of exclusion.

20 November 2025 in Quality in Sport
Verified
Journal Article
Open access
BŁBartosz Łuniewski
Bartosz Łuniewski
MOMonika Olszanska
Monika Olszanska
AMAngelika Macko
Angelika Macko
MŁMaria Łuniewska
Maria Łuniewska
INIga Maria Nowicka
Iga Maria Nowicka
UWUrszula Justyna Wojciechowska
Urszula Justyna Wojciechowska
Introduction: Tendinopathy refers to pathological changes in tendons that cause pain, functional impairment, and limited physical activity. These changes often result from repetitive overloading without adequate recovery, leading to microtrauma, collagen disorganization, vascular alterations, and chronic inflammation. While corticosteroids offer short-term relief, they may weaken tendon structure, and regenerative therapies like PRP and stem cells remain inconclusive. Recently, vitamin D has gained attention for its potential role in tendon healing. Low vitamin D levels are linked to higher tendinopathy risk and delayed recovery. This review aims to summarize current evidence on the role of vitamin D in tendon regeneration and its potential therapeutic application. Materials and methods: A review of selected literature in the PubMed, Scopus, Web of Science and Google Schoolar databases was conducted, using the following keywords: “Tendinopathy”, “Vitamin D”, “Tendon”. Conclusions: The potential role of vitamin D in tendon regeneration is a subject that offers novel perspectives on the treatment of tendinopathies. The therapeutic options currently available are limited in scope, frequently offering only symptomatic relief without addressing the underlying pathophysiology. The evidence from in vitro and in vivo experiments suggests that vitamin D can modulate inflammation, support collagen synthesis, and protect tenocytes from oxidative stress. Multidisciplinary management of tendinopathy should consider the assessment and correction of vitamin D deficiency, especially in older or physically active individuals. Further high-quality clinical studies are required to confirm these findings, determine optimal supplementation strategies, and evaluate long-term functional outcomes.

22 November 2025 in Quality in Sport
Verified
Journal Article
Open access
AMAngelika Macko
Angelika Macko
BŁBartosz Łuniewski
Bartosz Łuniewski
MŁMaria Łuniewska
Maria Łuniewska
ARAdam Rafałowicz
Adam Rafałowicz
MOMonika Olszanska
Monika Olszanska
UWUrszula Justyna Wojciechowska
Urszula Justyna Wojciechowska
Introduction: Idiopathic intracranial hypertension (IIH) is a rare neurological condition characterized by elevated intracranial pressure in the absence of a detectable cause. It predominantly affects obese women of childbearing age. The underlying pathophysiological mechanisms remain unclear, but increasing evidence suggests a significant role of obesity-related metabolic and hormonal disturbances. Materials and methods: A review of selected literature in the PubMed database was conducted, using the following keywords: “idiopathic intracranial hypertension”, “pseudotumor cerebri”, “obesity” Summary: The development of IIH appears to be multifactorial, involving impaired cerebrospinal fluid dynamics, venous outflow obstruction, and endocrine dysfunction. Obesity contributes through increased intra-abdominal and intracranial pressure, altered secretion of adipokines (such as leptin), and chronic low-grade inflammation. The review highlights the role of obesity as a modifiable risk factor and the impact of weight loss on symptom relief and disease progression. Conclusions: Understanding the link between obesity and IIH is crucial for effective prevention and treatment. Multidisciplinary care, including neurologists, ophthalmologists, and nutritionists, should focus on weight management and early detection of visual complications. Further research is needed to clarify the molecular mechanisms involved and to develop more targeted therapeutic strategies.

11 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
BŁBartosz Łuniewski
Bartosz Łuniewski
AMAngelika Macko
Angelika Macko
MŁMaria Łuniewska
Maria Łuniewska
KLKamil Klaudiusz Lauko
Kamil Klaudiusz Lauko
MOMonika Olszańska
Monika Olszańska
AJAleksandra Jurczuk
Aleksandra Jurczuk
Introduction: Prader-Willi syndrome (PWS) is a rare genetic disorder whose most characteristic and dangerous symptom is massive obesity. It develops as a result of neurohormonal abnormalities, abnormal appetite regulation and reduced energy expenditure. Due to its multifactorial nature, the treatment of obesity in PWS presents particular clinical challenges. Materials and methods: A review of selected literature in the PubMed database was conducted, using the following keywords: “Prader Willie Syndrom”, “Phisical excercise”, “Obesity”,”Treatment” Summary: This paper discusses the main mechanisms leading to the development of obesity in PWS, such as hypothalamic dysfunction, endocrine disruption (ghrelin, leptin, GH) and changes in body composition. Current therapeutic strategies - nutritional therapy adapted to the developmental stage of the patient, growth hormone treatment and the potential use of anti-obesity drugs - were analysed. Special attention was given to the role of physical activity, which, despite its limited effect on body weight, significantly improves fitness, muscle strength, body composition and quality of life in patients. Conclusions: The management of obesity in PWS requires an individualised, multidirectional approach based on collaboration between the specialist team and the family. Given the limited efficacy of available therapies, further research is needed into new treatments - both pharmacological and non-pharmacological - that are better adapted to the metabolic and behavioural specificities of this patient group.

9 June 2025 in Psychiatria i Psychologia Kliniczna
Verified
Journal Article
Open access
PDF file
BŁBartosz Łuniewski
Bartosz Łuniewski
AMAngelika Macko
Angelika Macko
MŁMaria Łuniewska
Maria Łuniewska
Stefan ModzelewskiStefan Modzelewski
Stefan Modzelewski
Napoleon WaszkiewiczNapoleon Waszkiewicz
Napoleon Waszkiewicz
Computer games play a significant role in modern entertainment, appealing to diverse age groups worldwide. This paper examines “internet gaming disorder” and “gaming disorder”, comparing their diagnostic criteria as defined by the American Psychiatric Association and the World Health Organization. While internet gaming disorder employs a broader set of criteria conducive to early identification of problematic gaming, gaming disorder focuses on more severe symptoms and significant functional impairment. These differences in diagnostic frameworks influence reported prevalence rates, highlighting the need for standardised methodologies. Key distinctions include internet gaming disorder’s emphasis on behaviours such as withdrawal, tolerance, and escapism, whereas gaming disorder prioritises impaired control and life disruption. Despite their differences, both classifications underscore gaming’s potential to induce behavioural addiction, comparable to substance use disorders. Diagnostic tools such as the IGDS9-SF and GAMES enhance the precision of evaluations; however, the absence of unified standards poses challenges in prevalence assessments and treatment approaches. These discrepancies complicate international comparisons and hinder the development of universal therapeutic strategies. Future research should aim to harmonise diagnostic criteria and improve tools to account for demographic variations and guide effective interventions. Establishing a balanced framework may aid in differentiating pathological gaming from non-harmful gaming behaviours, fostering better understanding and management of gaming-related disorders. Additionally, such a framework could prevent stigmatisation of non-pathological gaming, ensuring that interventions are appropriately targeted.

25 November 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MOMonika Olszanska
Monika Olszanska
AJAleksandra Jurczuk
Aleksandra Jurczuk
ARAdam Rafałowicz
Adam Rafałowicz
BŁBartosz Łuniewski
Bartosz Łuniewski
AMAngelika Macko
Angelika Macko
KMKinga Marciniak
Kinga Marciniak
Background: This review provides a critical analysis of selected clinical assessment instruments for depression, with emphasis on their utility in everyday medical practice and their adaptability to individual patient profiles. Given the multifactorial etiology and diverse symptomatology of depressive disorders, appropriate diagnostic tool selection is essential for accurate evaluation and monitoring. Aim: The paper reviews widely used depression assessment scales, including the Hamilton Depression Rating Scale (HDRS), Montgomery-Åsberg Depression Rating Scale (MADRS), Beck Depression Inventory (BDI), Patient Health Questionnaire (PHQ), Zung Self-Rating Depression Scale (ZSDS), Center for Epidemiologic Studies Depression Scale (CES-D), Depression Anxiety Stress Scales (DASS), and others, analyzing their relevance to various clinical populations, including athletes. Materials and Methods: A structured literature review was conducted using PubMed and Web of Science databases. Keywords included: major depressive disorder, psychometric assessment, screening tools, diagnostic evaluation, and mood disorders. Results: The examined tools differ in structure, scoring methods, and clinical applicability. Their utility varies depending on age, comorbidities, and context. Some instruments are better suited for older adults, postpartum women, or adolescents, while others may offer better sensitivity in athletic populations. Matching the tool to the individual's clinical and psychosocial profile improves diagnostic accuracy and treatment outcomes. Conclusions: Selecting depression assessment scales based on psychometric quality and population specificity—particularly in underrepresented groups such as athletes—can optimize diagnosis and facilitate effective, personalized treatment strategies.